Frankfurt - Delayed Quote EUR

Inspire Medical Systems, Inc. (2DR.F)

133.55
+2.50
+(1.91%)
As of 8:52:15 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
840,111
802,804
624,799
407,856
233,394
Cost of Revenue
128,938
122,986
96,576
66,115
33,279
Gross Profit
711,173
679,818
528,223
341,741
200,115
Operating Expense
661,357
643,735
568,494
389,333
239,965
Operating Income
49,816
36,083
-40,271
-47,592
-39,850
Net Non Operating Interest Income Expense
22,368
23,225
20,560
3,373
-2,003
Other Income Expense
-217
-855
-195
-49
-117
Pretax Income
71,967
58,453
-19,906
-44,268
-41,970
Tax Provision
5,461
4,944
1,247
613
72
Net Income Common Stockholders
66,506
53,509
-21,153
-44,881
-42,042
Diluted NI Available to Com Stockholders
66,506
53,509
-21,153
-44,881
-42,042
Basic EPS
2.24
1.80
-0.72
-1.60
-1.54
Diluted EPS
2.19
1.75
-0.72
-1.60
-1.54
Basic Average Shares
29,785.19
29,763.40
29,302.15
28,071.75
27,262.98
Diluted Average Shares
30,717.35
30,543.27
29,302.15
28,071.75
27,262.98
Total Operating Income as Reported
49,816
36,083
-40,271
-47,592
-39,850
Total Expenses
790,295
766,721
665,070
455,448
273,244
Net Income from Continuing & Discontinued Operation
66,506
53,509
-21,153
-44,881
-42,042
Normalized Income
66,506
53,509
-21,153
-44,881
-42,042
Interest Income
22,390
23,247
20,560
5,050
125
Interest Expense
--
22
0
1,677
2,128
Net Interest Income
22,368
23,225
20,560
3,373
-2,003
EBIT
72,208
58,475
-19,906
-42,591
-39,842
EBITDA
80,963
65,025
-17,060
-40,733
-38,624
Reconciled Cost of Revenue
128,938
122,986
96,576
66,115
33,279
Reconciled Depreciation
8,755
6,550
2,846
1,858
1,218
Net Income from Continuing Operation Net Minority Interest
66,506
53,509
-21,153
-44,881
-42,042
Normalized EBITDA
80,963
65,025
-17,060
-40,733
-38,624
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade